The major circulating metabolite of ketamine (norketamine) demonstrated activity at the identical receptor with much less affinity. Norketamine is about 1/3 as active as ketamine in lowering halothane prerequisites (MAC) with the rat. Prior to ketamine, Winograd says he only went to therapy because his family begged him to go. https://ketalinic.com/about-us/